Almost two million Brits could be at risk as 1.98m admitted they consume these drinks two or more times a week ...
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ADCETRIS® (brentuximab vedotin) in combination with ...